Sami-Sabinsa Group Named to Top 10 Pharma Laboratories by India Pharma Outlook

Press Release 2022

: 22 July 2022

The Sami-Sabinsa Group has been named one of the Top 10 Pharma Laboratories of 2022 by India Pharma Outlook in honor of the company’s exceptional diligence and inimitable approach to fulfilling customer requirements.

India Pharma Outlook, a business magazine focusing on the pharmaceutical industry in India, which includes nutraceuticals, published an Interview with Sami-Sabinsa founder and chairman Dr. Muhammed Majeed in its July issue.

“Heartfelt gratitude to all Sami-Sabinsa employees for their efforts in reaching this important milestone,” said Dr. Majeed. “This truly makes us all proud.

VISIT US

Edifício Koerich Beiramar Office
Avenida Mauro Ramos
1970- Sala 705-Centro
Florianópolis-SC
Brasil CEP 88.020-302

+55 48 3206 3682
info@sabinsa.com.br

CERTIFICATES

GLOBAL OFFICES

CONTACT US

Disclaimer

Please note that this website and information provided herein is not for final consumers of a finished food, beverage, dietary supplement product or cosmetic product, as the information contained herein does not refer to finished products for consumers.

The information provided on the website is intended only for producers of finished food, beverage, dietary supplement and cosmetic product.

The statements related to ingredients on the website, have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent any disease.

The website and information herein are available in various countries across the world, and hence statements or product information including its classification may not be applicable in your country.

Information and statements provided on the website, shall not be construed as license to practice, or recommendations to infringe, any patents or other intellectual property rights of Sabinsa and others.

By browsing further, You understand the above terms.